ARCH Venture Partners
archventure.com Direct investor
ARCH Venture Partners is a venture capital firm that invests in early-stage science-based companies, particularly in the life sciences and healthcare sectors. They focus on building disruptive companies from groundbreaking scientific discoveries.
ARCH Venture Partners is a venture capital firm headquartered in Chicago, United States. It invests directly in companies, from seed to growth, in biotech, healthcare, life sciences and physical sciences. Its stated cheque size is as little as $50K to as much as hundreds of millions of dollars, per company.
“We back great science. We partner with amazing people. We build disruptive companies. Everywhere.”
— ARCH Venture Partners, own website
- Layer
- Direct investor
- Type
- Venture capital
- Headquarters
- Chicago, United States
- Invests in
- global
- Sectors
- biotech, healthcare, life sciences, physical sciences
- Cheque size
- as little as $50K to as much as hundreds of millions of dollars, per company
Team, as ARCH Venture Partners publishes it
- Robert Nelsen Co-founder & Managing Director
- Keith Crandell Co-founder & Managing Director
- Kristina Burow Managing Director
- Steve Gillis, Ph.D. Managing Director
- Paul Berns Managing Director
- Clinton Bybee Co-founder & Managing Director, Emeritus
- Mark McDonnell Managing Director, CFO & CAO
- Jason Doren General Counsel
- Brian Cuneo Senior Partner
- David Moore Senior Partner
- Carol Suh Partner
- Ari Nowacek, M.D, Ph.D. Partner
Names and roles exactly as listed on archventure.com. Nothing else about these people is recorded.
Co-invests most often with
Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 132 co-investors found.
- EcoR1 Capital 8 shared companies: dewpointx.com, denalitherapeutics.com, sagerx.com, codiakbio.com…
- F-Prime Capital 7 shared companies: curie.bio, denalitherapeutics.com, beamtx.com, huamedicine.com…
- Sofinnova Investments, INC. 5 shared companies: karunatx.com, mallinckrodt.com, citytx.com, rapportrx.com…
- Leaps by Bayer 4 shared companies: boundlessbio.com, mozart-tx.com, dewpointx.com, egenesis.com
- RA Capital Management 4 shared companies: boundlessbio.com, bluebirdbio.com, vividion.com, metsera.com
- Atlas Venture 4 shared companies: alnylam.com, lifordi.com, nchromabio.com, remixtx.com
- Flagship Pioneering 4 shared companies: sana.com, generatebiomedicines.com, ksqtx.com, vesaliustx.com
- Aisling Capital Management LP 4 shared companies: scholarrock.com, syros.com, allergan.com, treeline.bio
- Frazier Life Sciences Management, LP 4 shared companies: aspenneuroscience.com, erasca.com, mazetx.com, parabilismed.com
- Foresite Capital 3 shared companies: bit.bio, denalitherapeutics.com, beamtx.com
and 122 more — the graph.
Where this comes from
Every fact above was read from a page ARCH Venture Partners publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- https://www.archventure.com/name, hq_country, hq_city, status, confidence
- https://www.archventure.com/about/is_investor, layer, type, invests_in_geographies, stage_min, stage_max, cheque_size, thesis_quote, thesis_quote_page, description
- https://www.archventure.com/portfolio/sectors
- https://www.archventure.com/team/people
Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.
Record 1027 · added 2026-08-28 · link last verified 2026-09-06 · confidence high
Similar investors
- Illinois VenturesVenture capital · Pre-seed – Series A · Chicago, United States
- InVivium CapitalVenture capital · Seed – Growth · Chicago, United States
- Flagship PioneeringVenture capital · Seed – Growth · Cambridge, United States
- Foresite CapitalVenture capital · Seed – Growth · United States
- Iaso VenturesVenture capital · Cambridge, United States
- 8VCVenture capital · Seed – Growth · Austin, United States